Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran

PHASE1CompletedINTERVENTIONAL

Enrollment

228

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

July 19, 2019

Study Completion Date

July 20, 2019

Conditions

Nausea

Interventions

DRUG

Bremelanotide

Sterile aqueous solution for injection, provided as an autoinjector pen

DRUG

Zofran

8 mg tablet (over-encapsulation in a capsule)

DRUG

Placebo

capsule

Trial Locations (1)

ICON Early Phase Serrvices, LLC, San Antonio